124 related articles for article (PubMed ID: 9491775)
1. Integrin subunit beta3 plays a crucial role in the movement of osteoclasts from the periosteum to the bone surface.
Holt I; Marshall MJ
J Cell Physiol; 1998 Apr; 175(1):1-9. PubMed ID: 9491775
[TBL] [Abstract][Full Text] [Related]
2. Osteoprotegerin is produced when prostaglandin synthesis is inhibited causing osteoclasts to detach from the surface of mouse parietal bone and attach to the endocranial membrane.
O'Brien EA; Williams JH; Marshall MJ
Bone; 2001 Feb; 28(2):208-14. PubMed ID: 11182380
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of prostaglandin synthesis leads to a change in adherence of mouse osteoclasts from bone to periosteum.
Marshall MJ; Holt I; Davie MW
Calcif Tissue Int; 1996 Sep; 59(3):207-13. PubMed ID: 8694899
[TBL] [Abstract][Full Text] [Related]
4. Contortrostatin, a homodimeric snake venom disintegrin, is a potent inhibitor of osteoclast attachment.
Mercer B; Markland F; Minkin C
J Bone Miner Res; 1998 Mar; 13(3):409-14. PubMed ID: 9525341
[TBL] [Abstract][Full Text] [Related]
5. Osteoprotegerin ligand regulates osteoclast adherence to the bone surface in mouse calvaria.
O'Brien EA; Williams JH; Marshall MJ
Biochem Biophys Res Commun; 2000 Aug; 274(2):281-90. PubMed ID: 10913332
[TBL] [Abstract][Full Text] [Related]
6. Osteoclasts are not the major source of interleukin-6 in mouse parietal bones.
Holt I; Davie MW; Marshall MJ
Bone; 1996 Mar; 18(3):221-6. PubMed ID: 8703576
[TBL] [Abstract][Full Text] [Related]
7. The number of tartrate-resistant acid phosphatase-positive osteoclasts on neonatal mouse parietal bones is decreased when prostaglandin synthesis is inhibited and increased in response to prostaglandin E2, parathyroid hormone, and 1,25 dihydroxyvitamin D3.
Marshall MJ; Holt I; Davie MW
Calcif Tissue Int; 1995 Mar; 56(3):240-5. PubMed ID: 7538445
[TBL] [Abstract][Full Text] [Related]
8. Antibody to beta3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat.
Crippes BA; Engleman VW; Settle SL; Delarco J; Ornberg RL; Helfrich MH; Horton MA; Nickols GA
Endocrinology; 1996 Mar; 137(3):918-24. PubMed ID: 8603604
[TBL] [Abstract][Full Text] [Related]
9. Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis.
Lubberts E; Oppers-Walgreen B; Pettit AR; Van Den Bersselaar L; Joosten LA; Goldring SR; Gravallese EM; Van Den Berg WB
Arthritis Rheum; 2002 Nov; 46(11):3055-64. PubMed ID: 12428250
[TBL] [Abstract][Full Text] [Related]
10. Activation of alphav beta3 integrin on human osteoclast-like cells stimulates adhesion and migration in response to osteopontin.
Faccio R; Grano M; Colucci S; Zallone AZ; Quaranta V; Pelletier AJ
Biochem Biophys Res Commun; 1998 Aug; 249(2):522-5. PubMed ID: 9712729
[TBL] [Abstract][Full Text] [Related]
11. Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts.
Komano Y; Nanki T; Hayashida K; Taniguchi K; Miyasaka N
Arthritis Res Ther; 2006; 8(5):R152. PubMed ID: 16987426
[TBL] [Abstract][Full Text] [Related]
12. [Osteoclasts and tartrate-resistant acid phosphatase-positive mononuclear cells in the mouse femur: a histochemical study].
Hasegawa K
Hokkaido Igaku Zasshi; 1994 Jan; 69(1):72-83. PubMed ID: 8119660
[TBL] [Abstract][Full Text] [Related]
13. IL-1alpha and IL-1beta have different effects on formation and activity of large osteoclasts.
Trebec-Reynolds DP; Voronov I; Heersche JN; Manolson MF
J Cell Biochem; 2010 Apr; 109(5):975-82. PubMed ID: 20108252
[TBL] [Abstract][Full Text] [Related]
14. A naturally occurring point mutation in the beta3 integrin MIDAS-like domain affects differently alphavbeta3 and alphaIIIbbeta3 receptor function.
Morel-Kopp MC; Melchior C; Chen P; Ammerlaan W; Lecompte T; Kaplan C; Kieffer N
Thromb Haemost; 2001 Dec; 86(6):1425-34. PubMed ID: 11776310
[TBL] [Abstract][Full Text] [Related]
15. Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin.
Shiotani A; Takami M; Itoh K; Shibasaki Y; Sasaki T
Anat Rec; 2002 Oct; 268(2):137-46. PubMed ID: 12221720
[TBL] [Abstract][Full Text] [Related]
16. 17beta-estradiol downregulates beta3-integrin expression in differentiating and mature human osteoclasts.
Saintier D; Burde MA; Rey JM; Maudelonde T; de Vernejoul MC; Cohen-Solal ME
J Cell Physiol; 2004 Feb; 198(2):269-76. PubMed ID: 14603529
[TBL] [Abstract][Full Text] [Related]
17. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
Kindle L; Rothe L; Kriss M; Osdoby P; Collin-Osdoby P
J Bone Miner Res; 2006 Feb; 21(2):193-206. PubMed ID: 16418775
[TBL] [Abstract][Full Text] [Related]
18. The mouse mammary tumor cell line, MMT060562, produces prostaglandin E2 and leukemia inhibitory factor and supports osteoclast formation in vitro via a stromal cell-dependent pathway.
Akatsu T; Ono K; Katayama Y; Tamura T; Nishikawa M; Kugai N; Yamamoto M; Nagata N
J Bone Miner Res; 1998 Mar; 13(3):400-8. PubMed ID: 9525340
[TBL] [Abstract][Full Text] [Related]
19. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients.
Grassi F; Cristino S; Toneguzzi S; Piacentini A; Facchini A; Lisignoli G
J Cell Physiol; 2004 May; 199(2):244-51. PubMed ID: 15040007
[TBL] [Abstract][Full Text] [Related]
20. Effect of medium pH on osteoclast activity and osteoclast formation in cultures of dispersed rabbit osteoclasts.
Shibutani T; Heersche JN
J Bone Miner Res; 1993 Mar; 8(3):331-6. PubMed ID: 7681246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
